Astrazeneca (AZN) Dividends Paid - Common (2009 - 2026)

Astrazeneca (AZN) has reported Dividends Paid - Common for 17 consecutive years, with -$3.3 billion the latest figure, recorded in Q1 2026.

• In Q1 2026, Dividends Paid - Common rose 1.79% year-over-year to -$3.3 billion; the TTM figure through Mar 2026 stood at $5.0 billion (up 16.59% YoY), while the FY2025 annual figure was $5.0 billion, up 7.39% from the prior year.
• Dividends Paid - Common came in at -$3.3 billion for Q1 2026 at Astrazeneca, down from $9.9 billion in the prior quarter.
• The five-year high for Dividends Paid - Common was $9.9 billion in Q4 2025, with the low at -$3.3 billion in Q1 2025.
• Average Dividends Paid - Common over 5 years is $22.8 million, with a median of -$1.6 billion recorded in 2024.
• Across the five-year window, Dividends Paid - Common plunged 52.3% in 2022 and soared 41.18% in 2025, its largest moves.
• Year by year, Dividends Paid - Common stood at -$3.0 billion in 2022, then soared by 99.26% to -$22.0 million in 2023, then jumped by 42168.18% to $9.3 billion in 2024, then rose by 7.39% to $9.9 billion in 2025, then tumbled by 133.07% to -$3.3 billion in 2026.
• According to Business Quant data, Dividends Paid - Common over the past three periods registered -$3.3 billion, $9.9 billion, and -$1.6 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.